Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam plus alfentanil versus propofol plus alfentanil for ERCP anesthesia in frail elderly patients
ChiCTR2400079414Phase 4Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam, propofol and alfentanil in Fragility (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Incidence of hypotension. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
remimazolampropofolalfentanil
03
Conditions
Fragility
Beyond the preview
Go deeper on ChiCTR2400079414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079414.